Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity

Authors :: Hugo Rodríguez-Zanella
Claudia Lerma
Sergio Mora-Canela
Victor Manuel Anguiano-Álvarez
Raúl Izaguirre-Ávila
Gustavo Rojas-Velasco
Flavio A Grimaldo-Gómez
Samuel Ramirez-Marroquin
Ángel Ramos-Enríquez
Adriana Torres-Machorro
Edgar García-Cruz
Evelyn Cortina-de la Rosa
Source :: Thrombosis Research
Publication Year :: 2020
Publisher :: Elsevier Ltd., 2020.
Abstract: Highlights • Clinical signs are not useful for detecting DVT in critically ill COVID-19 patients • DVT occurs despite full dose anticoagulation in critically ill COVID-19 patients • Severe COVID-19 patients present a high prevalence of bilateral DVT

Subjects :: medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Deep vein
Letter to the Editors-in-Chief
aPTT, activated partial thromboplastin time
Autopsy
030204 cardiovascular system & hematology
Asymptomatic
VTE, Venous thromboembolism
03 medical and health sciences
0302 clinical medicine
Internal medicine
PT, prothrombin time
medicine
cardiovascular diseases
Prospective cohort study
LDH, Lactate Dehydrogenase
business.industry
Critically ill
HS-CRP, High sensitivity C-Reactive protein
ASA, Acetylsalicylic acid
Hematology
medicine.disease
Thrombosis
LMWH, Low molecular weight heparin
DD, D-Dimer
ADP, adenosine diphosphate
Venous thrombosis
ICU, Intensive care unit
medicine.anatomical_structure
UFH, Unfractionated heparin
030220 oncology & carcinogenesis
medicine.symptom
DVT, Deep vein thrombosis
business

Tools